Literature DB >> 35066741

Discovery of antitumor effects of leczymes.

Takeo Tatsuta1, Masahiro Hosono2.   

Abstract

Sialic-acid binding lectin from bullfrog (Rana catesbeiana) eggs, cSBL, is a cytotoxic ribonuclease (RNase) belonging to the RNase A superfamily. cSBL is cytotoxic to tumor cells, such as malignant pleural mesothelioma by inducing apoptotic cell death caused by the degradation of RNA in tumor cells. In addition, we have reported some data that cSBL could be involved in the endoplasmic reticulum stress pathway, and it was also assumed to cause apoptotic cell death. The most significant property of cSBL is its specificity toward malignant cells. Furthermore, since the antitumor activity of cSBL was confirmed by in vivo experiments using mouse xenograft models, it is expected to be a candidate for clinical chemotherapy. Here, we summarize the history of cSBL, alternatively called "leczyme," with its present and future.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antitumor activity; Apoptosis; Lectin; Ribonuclease; Sialic acids

Mesh:

Substances:

Year:  2022        PMID: 35066741     DOI: 10.1007/s10719-021-10033-9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  67 in total

1.  Agglutinins of frog eggs: a new class of proteins causing preferential agglutination of tumor cells.

Authors:  H Kawauchi; F Sakakibara; K Watanabe
Journal:  Experientia       Date:  1975-03-15

2.  [Isolation of two agglutinins with different biological properties from the eggs of Rana catesbiana (author's transl)].

Authors:  F Sakakibara; G Takayanagi; H Ise; H Kawauchi
Journal:  Yakugaku Zasshi       Date:  1977-08       Impact factor: 0.302

3.  Amino acid sequence of sialic acid binding lectin from frog (Rana catesbeiana) eggs.

Authors:  K Titani; K Takio; M Kuwada; K Nitta; F Sakakibara; H Kawauchi; G Takayanagi; S Hakomori
Journal:  Biochemistry       Date:  1987-04-21       Impact factor: 3.162

4.  Amino acid sequence of a lectin from Japanese frog (Rana japonica) eggs.

Authors:  Y Kamiya; F Oyama; R Oyama; F Sakakibara; K Nitta; H Kawauchi; Y Takayanagi; K Titani
Journal:  J Biochem       Date:  1990-07       Impact factor: 3.387

5.  Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily.

Authors:  K Nitta; K Ozaki; M Ishikawa; S Furusawa; M Hosono; H Kawauchi; K Sasaki; Y Takayanagi; S Tsuiki; S Hakomori
Journal:  Cancer Res       Date:  1994-02-15       Impact factor: 12.701

6.  An anti-A-like lectin of Rana catesbiana eggs showing unusual reactivity.

Authors:  F Sakakibara; G Takayanagi; H Kawauchi; K Watanabe; S Hakomori
Journal:  Biochim Biophys Acta       Date:  1976-09-24

7.  Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs.

Authors:  K Nitta; K Ozaki; Y Tsukamoto; M Hosono; Y Ogawakonno; H Kawauchi; Y Takayanagi; S Tsuiki; S Hakomori
Journal:  Int J Oncol       Date:  1996-07       Impact factor: 5.650

8.  Egg lectin of Rana japonica and its receptor glycoprotein of Ehrlich tumor cells.

Authors:  F Sakakibara; H Kawauchi; G Takayanagi; H Ise
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

9.  A pyrimidine-guanine sequence-specific ribonuclease from Rana catesbeiana (bullfrog) oocytes.

Authors:  Y D Liao
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

10.  Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells.

Authors:  K Nitta; K Ozaki; Y Tsukamoto; S Furusawa; Y Ohkubo; H Takimoto; R Murata; M Hosono; N Hikichi; K Sasaki
Journal:  Cancer Res       Date:  1994-02-15       Impact factor: 12.701

View more
  1 in total

Review 1.  Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.

Authors:  Marta Menegazzi; Giovanni Gotte
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.